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Cognitive disorders represent a leading cause of disability in the aging population, of 
which dementia has the highest global burden. Early signs of dementia such as slow 
gait and memory complaints are known to present well before the overt manifestation 
of the disease. Motoric cognitive risk (MCR) syndrome characterized by the simultane-
ous presence of gait disturbances and memory complaints in older subjects has been 
proposed to study the close interactions between the physical and cognitive domains 
as well as a possible approach to identify individuals at increased risk of dementia. In 
addition, studies have shown MCR as a predictor of other negative outcomes in older 
adults, including disability, falls and death. However, the concept of MCR is still in its 
early stage and approach to the syndrome is still not well established. This review aims 
to put together the various aspects of MCR syndrome including its pathophysiology, 
diagnosis, epidemiology, and relationship with other geriatric conditions.
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inTRODUCTiOn
Older adults are known to have decreased functional capacity (e.g., sensory, cognitive, physical), 
which makes them vulnerable to adverse events such as disability, dependency, falls, or even death 
(1–5). Poor mobility of lower limbs with aging is one of the most commonly presented form of 
physical limitation in older individuals (6). Several studies have shown gait speed to predict major 
health-related events in older adults (6–8). Similarly, decline in memory is another common form 
of cognitive limitation associated with increase in age, which might potentially progress to demen-
tia (9, 10). Furthermore, evidences from past studies have shown coexistence of cognitive decline 
and gait abnormality (that might be of musculoskeletal or neuro-sensory-motor etiology) to be a 
common condition in older adults (3, 11, 12). Besides, these functional limitations are known to 
be the major causes of disability and dependency in older adults (7, 11, 13, 14).
Growing body of evidence suggests that simultaneous presence of cognitive complaints with 
reduced gait speed may indicate early signs of dementia (presenting decades before actual presenta-
tion of cognitive impairment) (15–20). Unfortunately, very little is known about how the actual 
interaction between the cognitive and physical domain (such as which domain triggers the other, or 
time-point of initiation) occurs with the phenomenon of aging. Intuitively, an entity that captures 
both physical and cognitive functional status of an aging individual could reflect a more implicit 
functional status of the individual. Moreover, such entity would aid researchers to better understand 
the interaction between cognition and physical domains in aging individuals who are at high-risk of 
dementia and other geriatric disorders.
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In this review, we discuss on a novel concept described as 
motoric cognitive risk (MCR) syndrome that captures the state of 
concomitant presence of gait disturbances and cognitive decline 
in older adults (20). Studies have shown MCR to be an effective 
tool in predicting various geriatric conditions such as dementia 
(19), falls (21), disability (22), and mortality (1).
GAiT AnD COGniTiOn in OLDeR ADULTS
Gait: Walking is a very common activity of daily living, which 
at a glance appears to be an entirely unsophisticated automated 
motor task. However, maintaining of normal gait is a much 
complex process requiring intact multisystem (nervous, sensory, 
musculoskeletal, cardiorespiratory) function and coordination 
(3, 16, 17). With increase in age, the parameters of gait (velocity, 
stride length, swing time) are affected as a result of disturbances 
in either of the musculoskeletal functions, locomotor function, 
balance, postural reflexes, sensory function and sensorimotor 
integration, and cardiorespiratory functions (23), resulting 
abnormal gait.
At present, gait speed or gait velocity has increasingly been 
implemented in clinical settings to evaluate functional status 
in older subjects and even to predict adverse events (1, 18, 21, 
22, 24). In addition, slow gait speed is thought to be a sensitive 
marker of cognitive decline with aging (18, 25–28). However, the 
methods and cut-off values for assessment of gait in older sub-
jects is known to vary widely. Moreover, every cut-point might 
be arbitrary because the relationship between gait speed and 
risk of negative outcomes follows a linear trend. Nevertheless, 
gait speed less than 0.8 m/s over a 4-m track is one of the most 
commonly used cut-points to assess gait speed in older subjects 
(29). The cut-point has been suggested to predict adverse events 
in older adults by the International Academy on Nutrition and 
Aging task force (29) and recommended for further clinical 
investigation by the European consensus on sarcopenia (30). On 
the other hand, the concept of “dis-mobility” describes a much 
slower gait speed of less than 0.6 m/s to be a relevant cut-point 
suitable for improving clinical care, research, and regulatory 
approval of treatments to improve mobility in older adults (31). 
Gait abnormalities have been identified from early neurological 
studies and subclassified as unsteady, ataxic, frontal, parkinso-
nian, neuropathic, hemiparetic, or spastic (23, 32) depending 
upon the nature of the disturbances that should be properly 
identified by physicians while assessing older adults.
Cognition: Cognition relates to the functioning processes of 
the brain, which tends to change with age (33). Cognitive func-
tions such as attention, intelligence, memory, processing speed, 
and executive function are known to decline with increase in 
age with varying degree between individuals (34), which could 
affect the overall functioning of an individual including gait. 
This alteration in cognition with aging has been associated 
primarily with decline in brain gray and white matter volume 
(35), brain hippocampus volume (36), and deposition of protein 
beta-amyloid in brain [a primary marker of Alzheimer’s disease 
(AD)] (37). Factors such as cardiovascular diseases (and associ-
ated risk factors), genetics, low level of education and depression 
have been identified as major contributing factors for cognitive 
decline (38), which could simultaneously influence the overall 
physical functioning. Assessment scales such as clinical demen-
tia rating (CDR) (39), Mini-Mental State Examination (40), and 
other forms of dementia screening questionnaire have been 
widely used to assess overall cognitive status of older adults.
Link between Gait and Cognition
As discussed before, gait is a sequel of multifactorial and multi-
system coordination, but primarily the result of neuromuscular 
interaction capacity of an individual. Anatomically speaking, 
brain frontal subcortical circuits predominantly mediate gait 
(41). Executive function (3, 42) and attention (42–44) have 
been suggested to be the primary cognitive processes associ-
ated. However, the frontal lobe itself is vulnerable to age-related 
changes (42), which could alter gait speed and cognition in 
older adults. In addition, declination or improvement in execu-
tive function and attention over time was found to effect gait 
progression (speed) in older adults (17, 27, 42). Increased brain 
subcortical white matter hyper-intensities (leukoaraiosis) (45) 
and decrease in cerebellar gray matter volume (46) and hip-
pocampal volumes (47) were found to be associated with reduced 
gait speed. This overlap between the brain areas controlling gait 
and cognition explains the relationship between slow gait and 
dementia pathologies. Furthermore, a dual-task methodology 
termed as “walking while talking” was developed for making 
the gait speed assessment more challenging and included the 
evaluation of cognition (48–50). The participant’s change in 
motor performance during dual-task was observed suggest-
ing requirement of additional cognitive resources to maintain 
multisystem coordination, which might be difficult to achieve 
for older individuals with cognitive limitation, leading to detri-
mental effects such as falls. Besides, a recent meta-analysis has 
shown evidences of brain structure to be associated with muscle 
structure and function (51), showing the consequential associa-
tion between these domains, which could alter gait function.
Factors Associated
Physical limitations and cognitive decline have been suggested 
to present bidirectional relationship (3, 17, 52). These conditions 
most likely share the common risk factors and pathways such as 
chronic inflammation, hormonal pathways, lifestyle factors, and 
even genetic pathway (11, 53–57).
Low-grade chronic inflammation or “inflamm-aging” might 
be the primary biological pathway shared by gait and cognition in 
older individuals (58–62). Atherosclerosis, a chronic inflamma-
tory condition in older adults is known to promote cardiovascular 
dysfunction that could increase functional loss (both cognitive 
and physical) in aged individuals (61, 63, 64). Furthermore, 
chronic inflammation is found to directly impact the central 
nervous system (e.g., neurofibrillary tangles, amyloid plaques) of 
older adults (65–67) and promote cardiovascular risk factors (59, 
61, 68, 69). Increased serum C-reactive protein, interleukin-6, 
and plasma tumor necrosis factor-α are the inflammatory mark-
ers associated with decrease in total brain volume (58, 65, 70, 71) 
that could affect cognition and gait simultaneously.
Cardiovascular risk factors (e.g., hypertension, diabetes, 
hyperlipidemia) are known to enhance incidences of cerebral 
FiGURe 1 | Diagrammatic presentation of motoric cognitive risk syndrome.
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ischemia affecting the periventricular white matter (64, 72, 73). 
As explained before, brain white matter plays an important role 
in the control of gait and cognitive processing and responsible 
for executive function (45, 64, 73). Similarly, other conditions 
such as neurodegeneration (e.g., in Parkinson’s disease) in older 
adults is well known to impact both cognition and motoric 
functions (74).
Needless to elaborate, nutritional factor is a key component to 
influence physical function in humans. Besides, abundant studies 
have shown that the deficiency of nutritional factors may affect 
both cognition and physical functions in older adults (53, 54, 75, 
76). Similarly, physical exercise is another factor that is well known 
to influence both cognition and physical limitations in older 
adults (77–80). Functional decline in older adults is also known 
to be influenced by hormonal alteration (such as downregulation 
of insulin-like growth factor) with aging (81) and genetic factors 
such as apolipoprotein-E4 (APOE-4 genotype) (55, 56).
MCR SYnDROMe
Motoric cognitive risk syndrome is defined as a condition charac-
terized by slowness of gait in the presence of subjective cognitive 
complaint in older adults without any form of dementia or mobil-
ity disability (1, 18–22). The theory that slowness of gait coexist-
ing with cognitive decline might be an early sign of dementia, 
which has been used in this novel entity, potentially resembling a 
pre-dementia syndrome (18, 19, 22) (Figure 1).
The following four criteria have been proposed to be met for 
the diagnosis of MCR (although the use of scales was not uniform 
in prior studies—Table 1) (1, 18–22): (1) presence of subjective 
cognitive complaints, assessed using standardized questionnaire 
(e.g., CDR, GDS, or AD screening questionnaire), (2) presence 
of slow gait: defined as velocity one SD or more below age- and 
sex-appropriate mean values, (3) preserved mobility, and (4) 
absence of dementia.
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Motoric cognitive risk was found to have a prevalence ranging 
from 2 to 18% (83, 84, 86, 87). A multi-country (17 countries 
worldwide) study showed an overall pooled prevalence of almost 
10% (83). These studies have shown MCR to have a higher 
prevalence and incidence in older age irrespective of gender. 
Based on the current availability of data, cross country compari-
son lowest prevalence of 2% was found in the United Kingdom 
and Australian cohort, and higher prevalence of 15% in Indian 
cohort and the highest prevalence of 16–18% was found in French 
population (83, 84, 86, 87).
Factors such as stroke, diabetes, obesity, depression, and seden-
tariness have been found to be associated with high risk of MCR in 
older adults (85, 86). Additional studies in much diverse sociode-
mographic settings are required for confirming the global burden 
of the condition and accordingly identify the associated risk factors.
MCR Syndrome As a Predictor Of
Dementia
Relevant links between cognition and gait have been established 
earlier. Older adults with cognitive impairment are known to have 
slower pace (26). Verghese and colleagues in the early 2000 impli-
cated that presence of neurological gait in older adults could predict 
the risk of dementia (18). However, predictive capacity of MCR with 
regards to subtypes of dementia was found to be different according 
to study cohort. In the Einstein Aging Study, MCR was found to be 
highly prevalent with age and was a strong predictor of vascular 
dementia (VaD) (19). Older subjects with MCR were found to be at 
more than 3-folds risk [hazard ratio (HR) = 3.27] of future demen-
tia (except AD) and particularly over 12-folds risk (HR = 12.81) of 
VaD. However, slow gait was the only gait parameter used which 
might have decreased the predictive validity of MCR.
In another multi-country study, MCR predicted dementia in 
multiple cohorts as well as pooled sample, with risks ranging from 
1.79- to 2.10-folds (83). Interestingly, MCR was found to be associ-
ated with increased risk of AD in two cohorts of the study with 
2.21- and 1.97-folds risk, while very few cases of VaD dementia 
were present in the cohort. However, the cohorts were limited to 
only 17 countries; therefore, the predictive strength cannot repre-
sent for all at-risk subjects [as the primary criteria of MCR cogni-
tive complaint and slow gait can vary demographically (88)], and 
not to forget the major risk factors that have varied demographic 
distribution. Additionally, information on APOE-4 genotype 
[that is known to impact progression of dementia (55)] was not 
included on this multi-country study, which could have further 
strengthened the validity of MCR dementia predictive capacity.
Interestingly, a retrospective study in Japanese older population 
has further elaborated the relation between MCR and dementia 
(89). The authors have reported the rate of conversion to dementia 
was 119.8/1,000 persons per year in MCR population, while the 
non-MCR group was 102.5/1,000 persons per year (OR = 1.38). 
Slow gait and low scores in executive function tests were found to 
be predictive of higher rate of conversion to dementia.
Falls
A very high frequency of falls (32–42% per year) in older people 
over 70  years has been estimated (90), which could result in 
many detrimental effects including disability or death (91, 92). 
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As discussed earlier, maintaining a normal well-balanced gait 
requires an efficient integration of motoric, cognitive, and psy-
chological function (3, 5, 16, 17) and the inability to maintain 
a normal gait could result in falls. Impairment in cognitive 
domains such as executive function, attention, processing speed, 
and memory is known to increase the risks of falls. However, age-
related loss in white matter integrity is thought to be one of the 
key mechanisms affecting the cognitive domain responsible (57, 
93). Thus, from our explanations earlier, we could expect MCR to 
be a sensitive predictor of falls in older adults.
A study by Callisaya and colleagues with a combined five large 
cohorts across three countries found subjects with MCR to be at 
44% at high risk of falls in pooled analysis (21). The study showed 
that slow gait [risk ratio (RR) = 1.30] and memory complaints 
(RR = 1.25) were also individually associated with increased risk 
of falls. Whereas, exclusion of MCR case in the study showed a 
slight decreased association of slow gait (RR = 1.25) and memory 
complaints (RR =  1.17) with falls. Even after adjustments for 
previous falls, MCR was significantly associated with falls 
(RR = 1.29) and multiple falls (RR = 1.37) in pooled analysis. No 
doubt, the results from the study show MCR to be an effective 
risk screening tool for falls, as the associations observed were 
relatively stronger. However, due to different criteria/procedures 
used for diagnosis of MCR and falls, heterogeneity was present in 
the pooled analysis.
Disability
Very few studies discussing the associations of MCR and disability 
are available. However, it can be expected that older individuals 
with coexisting memory decline and physical limitation are likely 
to be disabled (or lose independency) if not provided with proper 
medical attention at an early phase. A very recent study involving 
4,235 Japanese older adults (mean age of 72 years) has suggested 
MCR to be able to predict risk for disability (HR = 1.69) (22). 
The diagnostic criterion for disability was here regarded as 
certification by long-term care insurance. Nevertheless, the study 
has provided some perspectives for future studies, which could 
implement a more clinical diagnostic method for disability. The 
findings from this study have verified that individuals with slow 
gait and cognitive impairment are at high risk of disability, and 
more studies are demanded to confirm the findings.
Death
As discussed earlier, maintaining intact gait is a complex process 
requiring multisystem/multifunction coordination, therefore 
could represent a person’s holistic level of healthiness. Studies 
have shown gait speed to be a very strong predictor of survival 
(8) and cognitive impairment is also known to predict mortality 
(94). MCR involves both cognition and gait, has a high prevalence 
(83, 84, 86, 87), is known to predict falls (21), dementia (18, 19, 
22), and therefore could be a more sensitive predictor of death.
A study by Ayers and Verghese (1) including 11,867 participants 
from three different cohorts found MCR at baseline was associated 
with increased overall mortality (HR =  1.69) and increased risk 
of death even after adjustments for gait and memory test scores 
(HR = 1.19). The results from the study showed MCR to be a pre-
dictor of 2 years mortality, but MCR death predictive capacity in 
dementia subjects was found to be insignificant. However, it should 
be noted that the included cohorts of the study were from Europe 
and United states; therefore, results from the study cannot be inter-
preted as the global mortality predictive capacity of MCR. Moreover, 
the study population were community dwelling older adults, who 
tend to be in better shape compared to the institutionalized. As the 
study was a population-based study cases of diagnosed dementia 
could have been underreported, which could have underestimated 
the prediction of mortality in diagnosed dementia subjects.
THe PARADOX OF MCR SYnDROMe
An existing paradox of the MCR is whether to consider it as a con-
dition to treat or a mere matter for research purposes? As discussed 
above, MCR was found to predict wide spectrum of abnormalities 
in older adults (1, 19, 21, 22) and has a high prevalence ranging 
up to 18% (83, 84, 86, 87). For these reasons, attention on further 
approach of this novel syndrome is necessary. Although past stud-
ies have stressed on the versatility of diagnosing MCR (20), the 
clinical approach of the syndrome is vague. In the clinical scenario, 
we could only attempt to investigate the underlying pathologies 
of the condition and treat them in traditional manner (that 
requires various medical tests, despite of considering MCR easy to 
diagnose), which might require more resources and perhaps even 
create additional confusion in clinicians. On the other hand, if we 
consider it as screening tool to identify the at-risk population for 
the abnormalities it can predict, various effective tools for the pur-
pose already exist (with prior extensive studies involving different 
sociodemographic population settings). In this context, MCR 
might be more suitable as a research entity to exclusively investi-
gate the interactions between the physical and cognitive domains 
(which is not well understood yet) in older population with high 
risk of conditions that can be predicted by it. Furthermore, these 
understandings could enable us to design preventive strategies to 
ameliorate many geriatric conditions including dementia.
COnCLUSiOn
In summary, with population aging, the burden of cognitive 
disorders such as dementia is still escalating. Frequent coexist-
ence of physical limitation and cognitive decline occur in aging 
individuals, leading to many detrimental effects. MCR includes 
the evaluation of potential precursors of physical limitation 
(i.e., gait speed) and cognitive decline (i.e., subjective memory 
complaints) in order to predict multiple age-related conditions 
including dementia. Future perspective of MCR might be as a 
research tool to particularly investigate the relationship between 
physical and cognitive domain in older adults, further elucidate 
our understanding of the interaction between these two domains. 
Results from such studies could facilitate in designing more effec-
tive preventive intervention strategies against dementia and other 
age-related negative outcomes.
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